NCT01139853

Brief Summary

The overall objective of this research study is to determine the effect of a pre-operatively placed nasogastric tube compared to no nasogastric tube, on post-operative emesis rates and postoperative length of stay in infants with a primary diagnosis of pyloric stenosis treated with pyloromyotomy. This study will also examine the feasibility data of the pilot data to develop estimates of treatment effect of a pre-operative nasogastric tube on post-operative rate of emesis and length of stay to be used to determine the sample size of the definitive trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Jan 2010

Longer than P75 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 9, 2010

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

September 28, 2015

Status Verified

September 1, 2015

Enrollment Period

5 years

First QC Date

June 7, 2010

Last Update Submit

September 25, 2015

Conditions

Keywords

pyloric stenosisnasogastric tubepyloromyotomy

Outcome Measures

Primary Outcomes (1)

  • Feasibility

    2 years

Secondary Outcomes (2)

  • post-operative length of stay

    1 year

  • rates of post-operative emesis

    1 year

Study Arms (2)

Nasogastric Tube

ACTIVE COMPARATOR

10 French Nasogastric Tube inserted before surgery

Device: Nasogastric Tube

No Nasogastric Tube

NO INTERVENTION

Interventions

Insertion of a 10 French Nasogastric tube prior to surgery

Nasogastric Tube

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Male or female infant ≤ 6 months of age
  • Primary diagnosis of Pyloric Stenosis confirmed by ultrasound
  • Amendable to circumumbilical pyloromyotomy
  • Amendable to a minimum size 10 French nasogastric tube
  • Able to undergo general anesthesia
  • Parent or legal guardian able to give free and informed consent

You may not qualify if:

  • Contraindicated for circumumbilical pyloromyotomy
  • Contraindicated for a size 10 French nasogastric tube
  • Prematurity before 35 weeks' gestation
  • Bronchopulmonary dysplasia
  • Viral infection in the past 7 days
  • Cardiac malformation
  • Patent ductus arteriosis
  • Previous abdominal surgery
  • Concurrent surgical procedure scheduled
  • Parent or legal guardian unable to read, speak and understand English
  • Co-enrolled in a different interventional trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McMaster University Medical Center

Hamilton, Ontario, L8N3Z5, Canada

Location

Related Publications (1)

  • Flageole HH, Pemberton J. Post-Operative Impact of Nasogastric Tubes on length of stay in infants with pyloric Stenosis (POINTS): A prospective randomized controlled pilot trial. J Pediatr Surg. 2015 Oct;50(10):1681-5. doi: 10.1016/j.jpedsurg.2015.02.023. Epub 2015 Feb 19.

MeSH Terms

Conditions

Pyloric Stenosis

Interventions

Enteral Nutrition

Condition Hierarchy (Ancestors)

Gastric Outlet ObstructionStomach DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Dr. Helene Flageole, MD, FRCSC

    McMaster Children's Hopsital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2010

First Posted

June 9, 2010

Study Start

January 1, 2010

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

September 28, 2015

Record last verified: 2015-09

Locations